🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
BVS
$BVS
🔒 US EquitiesBioventus Inc.
AVG HISTORICAL GAP
+4.94%
MAX GAP RECORD
-30.85%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $BVS
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$BVS
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 03, 2026 Earnings Release 2026-11-03 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 05, 2026 Earnings Release 2026-08-05 (BEFORE OPEN) |
-5.44%
|
| May 06, 2026 Earnings Release 2026-05-06 (BEFORE OPEN) |
-2.57%
|
| Mar 05, 2026 Earnings Release 2026-03-05 (BEFORE OPEN) |
+6.26%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN) |
+8.54%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN) |
+5.70%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
-4.55%
|
| Mar 11, 2025 Earnings Release 2025-03-11 (BEFORE OPEN) |
+24.89%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
11.6%
Bullish Gaps (8)
Bearish Gaps (4)
Neutral / Flat (1)
📖 Intelligence Summary
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗